Patents by Inventor Mihail Obrocea

Mihail Obrocea has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CANCER IMMUNOTHERAPY AND METHOD OF TREATMENT
    Publication number: 20110274723
    Abstract: The instant disclosure relates to methods for treating a cancer patient with an active immunotherapeutic, wherein the methods include assessing a patient's pre-existing immunoreactivity to at least one target antigen, choosing an immunotherapeutic regimen based on the level of pre-existing immunoreactivity, and administering an active immunotherapeutic according to the regimen.
    Type: Application
    Filed: October 22, 2010
    Publication date: November 10, 2011
    Applicant: MANNKIND CORPORATION
    Inventors: Adrian Ion Bot, Zhiyong Qiu, David C. Diamond, Mihail Obrocea
  • Uses of anti-insulin-like growth factor 1 receptor antibodies
    Publication number: 20040202651
    Abstract: The present invention relates to a therapeutic method comprising administering anti-IGF-IR antibodies, particularly human anti-IGF-IR antibodies to a subject for the treatment of certain disorders preferably in conjunction with administration of another therapeutic agent. The invention further relates to pharmaceutical compositions comprising these antibodies and methods of using the antibodies and compositions thereof for treatment.
    Type: Application
    Filed: February 10, 2004
    Publication date: October 14, 2004
    Applicant: Pfizer Inc.
    Inventors: Bruce D. Cohen, Vahe Bedian, Mihail Obrocea, Jesus Gomez-Navarro, John D. Cusmano, Huifen F. Wang, Deborah J. Guyot, Kelly L. Page